|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61P 3/00 | (2006.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 3/14 | (2006.01) |
| (11) | Number of the document | 3773713 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19718562.2 |
| Date of filing the European patent application | 2019-04-05 | |
| (97) | Date of publication of the European application | 2021-02-17 |
| (45) | Date of publication and mention of the grant of the patent | 2025-07-09 |
| (46) | Date of publication of the claims translation | 2025-08-25 |
| (86) | Number | PCT/US2019/026173 |
| Date | 2019-04-05 |
| (87) | Number | WO 2019/195796 |
| Date | 2019-10-10 |
| (30) | Number | Date | Country code |
| 201862653731 P | 2018-04-06 | US |
| (72) |
GROMADA, Jesper , US
STEVIS, Panayiotis , US
ALTAREJOS, Judith , US
MURPHY, Andrew J. , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Leptino receptoriaus agonistinis antikūnas, skirtas kaulų masės didinimui subjektui, kuriam pasireiškia medžiagų apykaitos sutrikimas arba hipoleptinemija |
| A LEPTIN RECEPTOR AGONIST ANTIBODY FOR USE IN INCREASING BONE MASS IN A SUBJECT SUFFERING FROM METABOLIC DYSFUNCTION OR HYPOLEPTINEMIA |
| Payment date | Validity (years) | Amount | |
| 2026-03-19 | 8 | 185.00 EUR |
| 2027-04-05 |